November, 2006
No. 91 (11)

Editorials

Articles

Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study (206 Online Views)

EC Moser, EM Noordijk, FE van Leeuwen, JW Baars, J Thomas, P Carde, JH Meerwaldt, M van Glabbeke, HC Kluin-Nelemans

https://doi.org/10.3324/%25x

Home care management of patients affected by hematologic malignancies: a review (75 Online Views)

P Niscola, P de Fabritiis, C Cartoni, C Romani, F Sorrentino, T Dentamaro, D Piccioni, L Scaramucci, M Giovannini, S Amadori, F Mandelli

https://doi.org/10.3324/%25x

Letters to the Editor

Case Reports

Clinical Trial, Phase II

Comparative Studies

CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival (264 Online Views)

N Giuliani, S Bonomini, P Romagnani, M Lazzaretti, F Morandi, S Colla, S Tagliaferri, L Lasagni, F Annunziato, M Crugnola, V Rizzoli

https://doi.org/10.3324/%25x

The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma (164 Online Views)

ME Sarasquete, R Garcia-Sanz, A Armellini, M Fuertes, P Martin-Jimenez, M Sierra, M Del Carmen Chillon, M Alcoceba, A Balanzategui, F Ortega, JM Hernandez, A Sureda, L Palomera, M Gonzalez, JF San Miguel

https://doi.org/10.3324/%25x

CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy (164 Online Views)

AC Rawstron, G Laycock-Brown, G Hale, FE Davies, GJ Morgan, JA Child, P Hillmen, RG Owen

https://doi.org/10.3324/%25x